PA
GSK icon

Procyon Advisors’s GSK GSK Stock Holding History

Procyon Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,692
Closed -$86K – 528
2020
Q2 		$86K Buy
1,692
+302
+22% +$15.5K 0.05% 312
2020
Q1 		$66K Buy
1,390
+73
+6% +$3.89K 0.04% 293
2019
Q4 		$77K Buy
+1,317
New +$73.3K 0.05% 287

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Procyon Advisors's GSK Position: Q3 2020 in Review

Procyon Advisors sold out of GSK (GSK) in Q3 2020, closing a stake of 1,692 shares — an estimated $86K sold.

Procyon Advisors first reported a position in GSK in Q4 2019 and held it in 3 quarters. The position peaked at $86K in Q2 2020. 826 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

  • Procyon Advisors reported no remaining GSK position as of Q3 2020 after selling out during the quarter.
  • Procyon Advisors sold 1,692 GSK shares in Q3 2020, an estimated $86K.
  • Procyon Advisors first reported a position in GSK in Q4 2019 and held it in 3 quarters.
  • Procyon Advisors's GSK position peaked at $86K in Q2 2020.
  • 826 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.